Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 1
1982 1
1983 2
1984 1
1985 1
1987 1
1990 2
1991 1
1993 3
1994 1
1995 2
1996 2
1999 1
2000 3
2001 4
2002 4
2003 2
2004 4
2005 8
2006 5
2007 4
2008 7
2009 15
2010 24
2011 19
2012 20
2013 11
2014 12
2015 11
2016 9
2017 7
2018 11
2019 9
2020 9
2021 15
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

210 results
Results by year
Filters applied: . Clear all
Page 1
Cannabis and anxiety: a critical review of the evidence.
Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Crippa JA, et al. Among authors: zuardi aw. Hum Psychopharmacol. 2009 Oct;24(7):515-23. doi: 10.1002/hup.1048. Hum Psychopharmacol. 2009. PMID: 19693792 Review.
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder.
de Almeida CMO, Brito MMC, Bosaipo NB, Pimentel AV, Tumas V, Zuardi AW, Crippa JAS, Hallak JEC, Eckeli AL. de Almeida CMO, et al. Among authors: zuardi aw. Mov Disord. 2021 Jul;36(7):1711-1715. doi: 10.1002/mds.28577. Epub 2021 Mar 22. Mov Disord. 2021. PMID: 33754375 Clinical Trial.
History of cannabis as a medicine: a review.
Zuardi AW. Zuardi AW. Braz J Psychiatry. 2006 Jun;28(2):153-7. doi: 10.1590/s1516-44462006000200015. Epub 2006 Jun 26. Braz J Psychiatry. 2006. PMID: 16810401 Review.
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Bergamaschi MM, et al. Among authors: zuardi aw. Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
Biological bases for a possible effect of cannabidiol in Parkinson's disease.
Ferreira-Junior NC, Campos AC, Guimarães FS, Del-Bel E, Zimmermann PMDR, Brum Junior L, Hallak JE, Crippa JA, Zuardi AW. Ferreira-Junior NC, et al. Among authors: zuardi aw. Braz J Psychiatry. 2020 Apr;42(2):218-224. doi: 10.1590/1516-4446-2019-0460. Epub 2019 Jul 15. Braz J Psychiatry. 2020. PMID: 31314869 Free PMC article.
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.
Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Dos Santos RG, et al. Among authors: zuardi aw. Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18. Ther Adv Psychopharmacol. 2016. PMID: 27354908 Free PMC article. Review.
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma.
Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JE, Zuardi AW, Crippa JA, Reis C, Bahl M, Pizzichinni E, Maurici R, Pizzichinni MMM, Rocco PRM, Dal-Pizzol F. Vuolo F, et al. Among authors: zuardi aw. Eur J Pharmacol. 2019 Jan 15;843:251-259. doi: 10.1016/j.ejphar.2018.11.029. Epub 2018 Nov 24. Eur J Pharmacol. 2019. PMID: 30481497 Free article.
210 results